Aurora Cannabis May 2022 Investor Presentation

Aurora Cannabis presents its diversified business model across Canadian medical, international medical, and adult recreational segments. The presentation highlights #1 Canadian medical market share by revenue, 55% YoY growth in international medical, and margin-accretive acquisitions including premium brand Greybeard. Key focus areas include genetics licensing, biosynthesis innovation, and cost optimization toward positive adjusted EBITDA.